These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7178824)

  • 1. Effect of jejunoileal bypass operation and Billroth II resection on postprandial plasma pancreatic polypeptide release.
    Jorde R; Burhol PG
    Scand J Gastroenterol; 1982 Aug; 17(5):613-7. PubMed ID: 7178824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of jejunoileal bypass on postprandial release of plasma gastric inhibitory polypeptide (GIP).
    Jorde R; Burhol PG; Johnson JA
    Scand J Gastroenterol; 1981; 16(2):313-9. PubMed ID: 7031848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pancreatic polypeptide secretion before and after gastric bypass surgery for morbid obesity.
    Schrumpf E; Linnestad P; Nygaard K; Giercksky KE; Fausa O
    Scand J Gastroenterol; 1981; 16(8):1009-14. PubMed ID: 7038840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum pancreatic polypeptide responses to food and secretion in patients with Billroth I and Billroth II gastrectomies and in normal subjects.
    Lamers CB; Diemel CM; Jansen JB
    Surgery; 1982 Mar; 91(3):288-92. PubMed ID: 7058511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut and pancreatic hormones after jejunoileal bypass with 3:1 or 1:3 jejunoileal ratio.
    Sørensen TI; Lauritsen KB; Holst JJ; Stadil F; Andersen B
    Digestion; 1983; 26(3):137-45. PubMed ID: 6343164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Behavior of plasma pancreatic polypeptides and motilin in obese patients subjected to biliopancreatic bypass].
    Civalleri D; Bloom SR; Sarson DL; Gianetta E; Bonalumi U; Friedman D; Pitton L; Brignole E; Binda PL; Degrandi R; Scopinaro N
    Boll Soc Ital Biol Sper; 1980 Oct; 56(19):1929-35. PubMed ID: 7459103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancreatic polypeptide, pancreatic glucagon and enteroglucagon in morbid obesity and following gastric bypass operation.
    Meryn S; Stein D; Straus EW
    Int J Obes; 1986; 10(1):37-42. PubMed ID: 3710688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of partial gastrectomy with Billroth II or Roux-en-Y anastomosis on postprandial and cholecystokinin-stimulated gallbladder contraction and secretion of cholecystokinin and pancreatic polypeptide.
    Rieu PN; Jansen JB; Hopman WP; Joosten HJ; Lamers CB
    Dig Dis Sci; 1990 Sep; 35(9):1066-72. PubMed ID: 2390921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma cholecystokinin (CCK) before and after a jejunoileal bypass operation in obese patients with reference to appetite regulation.
    Burhol PG; Jenssen TG; Jorde R; Lygren I; Johnson JA
    Int J Obes; 1984; 8(3):233-6. PubMed ID: 6746190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of a gastric partitioning operation for morbid obesity on the secretion of gastric inhibitory polypeptide and pancreatic polypeptide.
    Amland PF; Jorde R; Kildebo S; Burhol PG; Giercksky KE
    Scand J Gastroenterol; 1984 Sep; 19(6):857-61. PubMed ID: 6393318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucose handling in morbid obesity and the effects of surgically induced weight loss.
    Dooner J; Burget D; Cleator IG
    JPEN J Parenter Enteral Nutr; 1984; 8(6):660-4. PubMed ID: 6394779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective comparison of gastric and jejunoileal bypass procedures for morbid obesity.
    Griffen WO; Young VL; Stevenson CC
    Ann Surg; 1977 Oct; 186(4):500-9. PubMed ID: 907395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meal stimulated levels of pancreatic polypeptide (PP) and vasoactive intestinal polypeptide (VIP) in gastroplasty for morbid obesity.
    Miskowiak J; Andersen B; Stadil F; Fahrenkrug J
    Regul Pept; 1985 Nov; 12(3):231-6. PubMed ID: 4081128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Release of gastric inhibitory polypeptide (GIP) and gastrin after a test meal with a low glucose load in patients after BII resection, proximal duodenopancreatectomy (PDP) and jejunoileal bypass.
    Klapdor R
    Res Exp Med (Berl); 1982; 181(1):11-8. PubMed ID: 7134635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma enteroglucagon after jejunoileal bypass with 3:1 or 1:3 jejunoileal ratio.
    Holst JJ; Sørensen TI; Andersen AN; Stadil F; Andersen B; Lauritsen KB; Klein HC
    Scand J Gastroenterol; 1979; 14(2):205-7. PubMed ID: 432544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut hormone changes after jejunoileal (JIB) or biliopancreatic (BPB) bypass surgery for morbid obesity.
    Sarson DL; Scopinaro N; Bloom SR
    Int J Obes; 1981; 5(5):471-80. PubMed ID: 6796532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastric bypass in the operative revision of the failed jejunoileal bypass.
    LaFave JW; Alden JF
    Arch Surg; 1979 Apr; 114(4):438-44. PubMed ID: 435057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positive results of jejunoileal bypass surgery: emphasis on lipids with comparison to gastric bypass.
    Buchwald H; Rucker RD; Schwartz MZ; Varco RL
    Int J Obes; 1981; 5(4):399-404. PubMed ID: 7309324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diurnal GIP, PP and insulin levels in morbid obesity before and after stapled gastric partitioning with gastro-gastrostomy.
    Amland PF; Jorde R; Giercksky KE; Burhol PG
    Int J Obes; 1984; 8(2):117-22. PubMed ID: 6373640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastric and jejunoileal bypass. A comparison in the treatment of morbid obesity.
    Alden JF
    Arch Surg; 1977 Jul; 112(7):799-806. PubMed ID: 880023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.